LG to begin selling diabetes drug overseas in March

Home > Business > Industry

print dictionary print

LG to begin selling diabetes drug overseas in March

The diabetes treatment drug Zemiglo by LG Life Sciences will make its overseas debut in March, when it enters markets in India and five Central American countries, the company announced Wednesday.

The five Central American countries include Guatemala, Honduras, El Salvador, Ecuador and Costa Rica.

The company obtained sales permits in nine countries last year. LG has been working with Sanofi-Aventis and Stendhal since 2013 to jointly sell Zemiglo in 104 countries.





More in Industry

Chaebol heads talk shop at closed-door dinner

Arkana arrives

Low battery

Kitting up

I've got two words for you: Biodegradable plastic

Log in to Twitter or Facebook account to connect
with the Korea JoongAng Daily
help-image Social comment?
lock icon

To write comments, please log in to one of the accounts.

Standards Board Policy (0/250자)

What’s Popular Now